113 related articles for article (PubMed ID: 10756082)
1. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519.
Vanderlugt CL; Rahbe SM; Elliott PJ; Dal Canto MC; Miller SD
J Autoimmun; 2000 May; 14(3):205-11. PubMed ID: 10756082
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
3. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
4. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
5. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.
Kennedy KJ; Smith WS; Miller SD; Karpus WJ
J Immunol; 1997 Jul; 159(2):1036-44. PubMed ID: 9218627
[TBL] [Abstract][Full Text] [Related]
6. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
[TBL] [Abstract][Full Text] [Related]
9. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
[TBL] [Abstract][Full Text] [Related]
10. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
11. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
Nicolò C; Sali M; Di Sante G; Geloso MC; Signori E; Penitente R; Uniyal S; Rinaldi M; Ingrosso L; Fazio VM; Chan BM; Delogu G; Ria F
J Immunol; 2010 Jan; 184(1):222-35. PubMed ID: 19949067
[TBL] [Abstract][Full Text] [Related]
13. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
[TBL] [Abstract][Full Text] [Related]
14. The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis.
Batoulis H; Uhl M; Addicks K; Lehmann PV; Kuerten S
Glia; 2012 May; 60(5):794-805. PubMed ID: 22319015
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
[TBL] [Abstract][Full Text] [Related]
16. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
Mangalam AK; Khare M; Krco C; Rodriguez M; David C
Eur J Immunol; 2004 Jan; 34(1):280-90. PubMed ID: 14971054
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
Han D; Tian Y; Zhang M; Zhou Z; Lu J
Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
[TBL] [Abstract][Full Text] [Related]
18. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
[TBL] [Abstract][Full Text] [Related]
19. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
[TBL] [Abstract][Full Text] [Related]
20. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]